News

Owens & Minor Names Chief Operating Officer

Owens & Minor, a global healthcare solutions company providing essential products, services and technology solutions that support care delivery in leading hospitals, health systems and research centers around the world, today announced Marc Rottink as Chief Operating Officer (COO) of Owens & Minor, effective immediately.

Rottink brings almost three decades of experience in leading global, multi-site healthcare supply chain operations, including strategic transformation, oversight and management of global inventory assets and distribution operations, integrated business planning, systems implementation, and cross-functional operations alignment. Most recently, Marc served as Senior Vice President of Global Supply Chain and Customer Care for Smith + Nephew. Under his leadership, Smith + Nephew saw significant improvement in its manufacturing operations, as well as sales, inventory, and operational planning (SIOP), greatly enhancing customer fulfillment levels. Prior to Smith + Nephew, Marc served as Vice President of Global Supply Chain for Medtronic’s Restorative Therapies Group.

“In logistics, operational excellence is important, but in healthcare logistics, it’s critical,” said Christian Cook, chairman and interim CEO, Owens & Minor, and managing director at Platinum Equity. “We’re making significant investments in our operations through automation and we’re confident that Marc’s impressive history of successfully leading global operational transformation will be a pivotal asset as Owens & Minor continues to improve the customer experience.”

“Throughout my career, I’ve had great passion for developing and implementing large-scale strategies that help supply chains and product manufacturing operate more efficiently and more responsively,” said Marc Rottink, Chief Operating Officer (COO), Owens & Minor. “I’m more than thrilled to join Owens & Minor and excited for the opportunity to innovate and improve the backbone of our strength—our 140+ years of operational expertise—and take it to the next level.”

On December 31, 2025, Owens & Minor announced a new chapter in its long and storied history: the medical distribution, products and technology services business, formerly referred to as Products & Healthcare Services (P&HS), is now part of the Platinum Equity portfolio. The company continues to operate as a private standalone company under the Owens & Minor name, carrying on the legacy of excellence and service the company has long been known for.

Read more here.

Recent News

06/02/2026

TearSolutions Receives FDA Orphan Drug and Fast Track Designations for Lacripep® in Neurotrophic Keratitis and Initiates Phase 2 Clinical Trial with First Patients Dosed

TearSolutions, Inc. (“TearSolutions”), a clinical-stage biotechnology company developing novel ophthalmic therapeutics, today announced receiving Food and Drug Administration (FDA) Orphan Drug (ODD) and Fast Track Designations for Lacripep in Neurotrophic Keratitis (NK) and initiating a Phase 2 clinical trial with first patients dosed. The FDA’s ODD provides incentives, including tax credits for clinical testing and

06/02/2026

Contraline Announces $92.5 Million Series B Financing to Advance NES/T Male Contraceptive into Late-Stage Development

Contraline, Inc., a clinical-stage biopharmaceutical company developing novel male contraceptives, today announced the closing of a $92.5 million Series B financing co-led by BVF Partners L.P. and RA Capital Management, with participation from GV (Google Ventures), Lumira Ventures, Invus, and other new and existing investors. In conjunction with the closing of the Series B financing,

06/02/2026

GEN Names BioHealth Capital Region a Top 3 U.S. Biopharma Cluster for Fourth Year in a Row

The BioHealth Capital Region, spanning Maryland, Virginia, and Washington, D.C., has once again been named one of the nation’s Top 3 biopharma clusters by Genetic Engineering & Biotechnology News (GEN), marking the region’s fourth consecutive year in the Top 3. GEN’s 2026 “Top 10 U.S. Biopharma Clusters” ranking was authored by Alex Philippidis, Senior Business